References
Abrahamsen, J. F., Rusten, L., Bakken, A. M., & Bruserud, Ø. (2004). Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5% dimethylsulfoxide instead of 10% dimethylsulfoxide. Transfusion, 44, 785-789.
Berz, D., McCormack, E. M., Winer, E. S., Colvin, G. A., & Quesenberry, P. J. (2007). Cryopreservation of hematopoietic stem cells. American Journal of Hematology, 82, 463-472. doi:10.1002/ajh.20707
Bojanic, I., Cepulic, B. G., Mazic, S., Batinic, D., Nemet, D., & Labar, B. (2008). Toxicity related to autologous peripheral blood haematopoietic progenitor cell infusion is associated with number of granulocytes in graft, gender and diagnosis of multiple myeloma. Vox Sanguinis, 95(1), 70-75. doi:10.1111/j.1423-0410.2008.01060.x
Calmels, B., Lemarié, C., Esterni, B., Malugani, C., Charbonnier, A., Coso, D., … Chabannon, C. (2007). Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product. Transfusion, 47, 1268-1275.
Campbell-Yeo, M., Ranger, M., Johnston, C., & Fergusson, D. (2009). Controlling bias in complex nursing intervention studies: A checklist. Canadian Journal of Nursing Research, 41(4), 31-50.
Comeau, T. B., Epstein, J. B., & Migas, C. (2001). Taste and smell dysfunction in patients receiving chemotherapy: A review of current knowledge. Supportive Care in Cancer, 9, 575-580.
Donmez, A., Tombuloglu, M., Gungor, A., Soyer, N., Saydam, G., & Cagirgan, S. (2007). Clinical side effects during peripheral blood progenitor cell infusion. Transfusion and Apheresis Science, 36(1), 95-101. doi:10.1016/j.transci.2006.05.019
Egerer, G., Eisenlohr, K., Gronkowski, M., Burhenne, J., Riedel, K. D., & Mikus, G. (2010). The NK receptor antagonist aprepitant does not alter the pharmacokinetics of high-dose melphalan chemotherapy in patients with multiple myeloma. British Journal of Clinical Pharmacology, 70, 903-907. doi:10.1111/j.1365-2125.2010.03792.x
Egorin, M. J., Rosen, D. M., Sridhara, R., Sensenbrenner, L., & Cottler-Fox, M. (1998). Plasma concentrations and pharmacokinetics of dimethylsulfoxide and its metabolites in patients undergoing peripheral-blood stem cell transplants. Journal of Clinical Oncology, 16, 610-615.
Ferrucci, P. F., Martinoni, A., Cocorocchio, E., Civelli, M., Cinieri, S., Cardinale, D., … Martinelli, G. (2000). Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy. Bone Marrow Transplantation, 25, 173-177.
Hawkins, R., & Grunberg, S. (2009). Chemotherapy-induced nausea and vomiting: Challenges and opportunities for improved patient outcomes. Clinical Journal of Oncology Nursing, 13, 54-64. doi:10.1188/09.CJON.54-64
Hessell, P. G., Lloyd-Jones, J. G., Muir, N. C., Parr, G. D., & Sugden, K. (1989). A comparison of the availability of prochlorperazine following i.m. buccal and oral administration. International Journal of Pharmaceutics, 52, 159-164.
Jacob, S. W., & de la Torre, J. C. (2009). Pharmacology of dimethyl sulfoxide in cardiac and CNS damage. Pharmacological Reports, 61, 225-235.
Jokela, R. M., Cakmakkaya, O. S., Danzeisen, O., Korttila, K. T., Kranke, P., Malhotra, A., … Apfel, C. C. (2009). Ondansetron has similar clinical efficacy against both nausea and vomiting. Anaesthesia, 64, 147-151. doi:10.1111/j.1365-2044.2008.05732.x
Kessinger, A., Schmit-Pokorny, K., Smith, D., & Armitage, J. (1990). Cryopreservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transplantation, 5(Suppl. 1), 25-27.
Kessinger, A., & Sharp, J. G. (2003). The whys and hows of hematopoietic progenitor and stem cell mobilization. Bone Marrow Transplantation, 31, 319-329.
Khera, N., Jinneman, J., Storer, B. E., Heimfeld, S., O'Meara, M. M., Chauncey, T. R., … Linenberger, M. (2012). Limiting the daily total nucleated cell dose of cryopreserved peripheral blood stem cell products for autologous transplantation improves infusion-related safety with no adverse impact on hematopoietic engraftment. Biology of Blood and Marrow Transplantation, 18, 220-228. doi:10.1016/j.bbmt.2011.06.003
Kim, D. H., Jamal, N., Saragosa, R., Loach, D., Wright, J., Gupta, V., … Messner, H. A. (2007). Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCsT) compared to fresh allografts. Biology of Blood and Marrow Transplantation, 13, 1233-1243. doi:10.1016/j.bbmt.2007.07.003
Liseth, K., Ersvær, E., Abrahamsen, J. F., Nesthus, I., Ryningen, A., & Bruserud, Ø. (2009). Long-term cryopreservation of autologous stem cell grafts: A clinical and experimental study of hematopoietic and immunocompetent cells. Transfusion, 49, 1709-1719. doi:10.1111/j.1537-2995.2009.02180.x
Milone, G., Mercurio, S., Strano, A., Leotta, S., Pinto, V., Battiato, K., … Giustolisi, R. (2007). Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age. Cytotherapy, 9, 348-355. doi:10.1080/14653240701326756
Molassiotis, A., Coventry, P. A., Stricker, C. T., Clements, C., Eaby, B., Velders, L., … Gralla, R. J. (2007). Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: The MASCC antiemesis tool. Journal of Pain and Symptom Management, 34, 148-159. doi:10.1016/j.jpainsymman.2006.10.018
Okamoto, Y., Takaue, Y., Saito, S., Shimizu, T., Suzue, T., Abe, T., … Kawano, Y. (1993). Toxicities associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active cancer. Transfusion, 33, 578-581.
Potter, P., Eisenberg, S., Cain, K. C., & Berry, D. L. (2011). Orange interventions for symptoms associated with dimethyl sulfoxide during stem cell reinfusions: A feasibility study. Cancer Nursing, 34, 361-368. doi:10.1097/NCC.0b013e31820641a5
Prior, D., Mitchell, A., Nebauer, M., & Smith, M. (2000). Oncology nurses' experience of dimethyl sulfoxide odor. Cancer Nursing, 23, 134-140.
Quigley, E. M., Hasler, W. L., & Parkman, H. P. (2001). AGA technical review on nausea and vomiting. Gastroenterology, 120(1), 263-286.
Rowley, S., MacLeod, B., Heimfeld, S., Holmberg, L., & Bensinger, W. (1999). Severe central nervous system toxicity associated with the infusion of cryopreserved PBSCs components. Cytotherapy, 1, 311-317.
Sauer-Heilborn, A., Kadidlo, D., & McCullough, J. (2004). Patient care during infusion of hematopoietic progenitor cells. Transfusion, 44, 907-916.
Simons, K. J., Watson, W. T., Martin, T. J., Chen, X. Y., & Simons, F. E. (1990). Diphenhydramine: Pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children. Journal of Clinical Pharmacology, 30, 665-671.
Stroncek, D. F., Fautsch, S. K., Lasky, L. C., Hurd, D. D., Ramsay, N. K., & McCullough, J. (1991). Adverse reactions in patients transfused with cryopreserved marrow. Transfusion, 31, 521-526.
Syme, R., Bewick, M., Stewart, D., Porter, K., Chadderton, T., & Glück, S. (2004). The role of depletion of dimethyl sulfoxide before autografting: On hematologic recovery, side effects, and toxicity. Biology of Blood and Marrow Transplantation, 10, 135-141.
Tompkins Stricker, C., & Eaby, B. (2010). Chemotherapy-induced nausea and vomiting. In C. Brown (Ed.), A guide to oncology symptom management (pp. 91-122). Pittsburgh, PA: Oncology Nursing Society.
Zambelli, A., Poggi, G., Da Prada, G., Pedrazzoli, P., Cuomo, A., Miotti, D., … Robustelli della Cuna, G. (1998). Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Research, 18(6B), 4705-4708.